以下文章来源于动脉生物制造 ，作者武瑛港 动脉生物制造 . 动脉网(www.vbdata.cn)聚焦于技术驱动下生命健康领域产业创新和变革的报道与研究。 /生物制造产业社群/ 让上下游聚在一起, 未来食农、绿色化工、大健康、美妆个护 等产业同行❤️↓ 全球政策进展 | 重庆市 【SynBioCon】 获 悉， 9 月 23 日，根据重庆日报信息，重庆市璧山区举行招商引资项目集中签约 活动暨产业创新综合体集群培育启动大会， 32 个总投资达 145.3 亿元 的项目完成签约。 项目涵盖 生物制造、生物医药、智能装备 、新一代电子信息制造、智能网联新能源汽车、现代物流等 多个领域，同步启动多个产业创新综合体共建合作。 其中在生物制造领域，璧山区签约了 重庆生物制造产业中试平台项目 ，聚焦智能化生物发酵等生物制造关 键技术领域，计划打造集"工艺优化、中试验证、数据集成、智能制造"功能于一体的 国家级生物制造中试 平台 ，致力于成为具有全国辨识度的 生物制造产业"西南中心"。 据了解， 2025 年 4 月，重庆市政府发布的《关于做好 2025 年市级重点项目实施有关工作的通知》显示， 2025 年市级重点项目包括开 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002513 证券简称：蓝丰生化公告编号：2025-057 江苏蓝丰生物化工股份有限公司 关于公司股票交易异常波动的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在虚假记载、误导性陈述或者重大遗 漏。 一、股票交易异常波动情况 江苏蓝丰生物化工股份有限公司（以下简称"公司"）股票交易价格于2025年9月25日、2025年9月26日连 续两个交易日收盘价格涨幅偏离值累计超过20%，根据《深圳证券交易所交易规则》等有关规定，属于 股票交易异常波动的情形。 二、公司关注并核实情况的说明 针对公司股票交易异常波动，公司对有关事项进行了核查，现就有关情况说明如下： 1、公司前期披露的信息不存在需要更正、补充之处。 2、公司未发现近期有公共媒体报道了可能或已经对本公司股票交易价格产生较大影响的未公开重大信 息。 3、公司目前经营情况正常，内外部经营环境未发生重大变化。 除上述事项外，公司董事会确认，公司目前没有任何根据《深圳证券交易所股票上市规则》等有关规定 应予以披露而未披露的事项或与该事项有关的筹划、商谈、意向、协议等；董事会也未获悉公司有根 ...

【DT新材料】 获 悉， 9月14日，"第二届国际绿碳科学大会（ICGC 2025）"在青岛开幕，首届" 绿碳杰出成就奖 "颁发，何鸣元、谭天伟、米夏埃 尔·格雷策尔三位科学家获得殊荣。在 绿色生物制造领域 ， 中国工程院院士、北京化工大学谭天伟教授 是中国生物化工领域的领军者，以创新驱动生 物炼制行业变革，系统推动我国绿色生物制造体系建设与发展，为全球可持续发展贡献"中国方案"。 会议期间， 《中国科学报》记者对 中国工程院院士谭天伟进行了专访。 《中国科学报》 ：作为中国生物化工领域的领军者，你对获得首届"绿碳杰出成就奖"有何感想？你认为中国发展绿色生物制造对于实现"双碳"目标的 核心价值是什么？未来十年，绿色生物制造的最关键突破点会在哪些方向？ 谭天伟 ：这份荣誉不属于我个人，属于我的团队，属于所有为中国绿色生物制造事业奋斗的同仁。这既是对我们过去工作的肯定，也是对"生物制 造"这一战略方向重要性的认可。 中国发展绿色生物制造对于实现"双碳"目标的核心价值在于提供了一条 "不减增长、只减排放"的发展新路径，是破解"发展"与"降碳"两难命题的关 键。 未来十年，绿色生物制造领域将在人工智能驱动的菌种智造、 ...

Core Insights - The event "Biomanufacturing Leading the Future" was successfully held in Hefei as part of the 2025 World Manufacturing Conference, attracting over 230 participants from various sectors [1][3] - The focus was on the biomanufacturing industry, discussing key common links and development hotspots, and aiming to create a comprehensive biomanufacturing ecosystem [3][4] Industry Development - Anhui Province has established a comprehensive biomanufacturing industry system covering six sectors: biopharmaceuticals, bio-food, bio-energy, biomaterials, biochemistry, and enzyme preparations [3] - The province has developed three billion-level industry clusters in biopharmaceuticals, bio-food, and bio-energy, with leading companies like Huaheng Bio and Fengyuan Group [3][4] - A 3 billion yuan biomanufacturing industry fund has been established through cooperation between central and local governments [3] Strategic Initiatives - Hefei is integrating biomanufacturing into its new industrial cluster system, forming a dedicated task force and implementing supportive policies [4] - The establishment of the Synthetic Biology Innovation Research Institute and the Hefei (Changfeng) Synthetic Biomanufacturing Industrial Park aims to create a nationally influential biomanufacturing hub [4] Collaborative Efforts - Key projects and funds were signed during the event, including the Synthetic Biology Multiscale Incubation Center and AI-driven biomanufacturing platforms [4] - The establishment of the Anhui Biomanufacturing Industry Alliance will facilitate the gathering of innovative resources and promote the commercialization of research outcomes [7] Future Outlook - Anhui plans to optimize its industrial layout and enhance collaboration among government, industry, academia, research, finance, and services to foster a "four-chain integration" industrial ecosystem [8]

Core Insights - The event "Biomanufacturing Leading Future Industrial Pattern" held in Changfeng, Hefei, is part of the 2025 World Manufacturing Conference, focusing on biomanufacturing as a key industry [1][3] - The Hefei Biomanufacturing Provincial Future Industry Pilot Zone is the only pilot zone in Anhui Province dedicated to life sciences [1][3] Group 1: Event Overview - The event emphasized the importance of biomanufacturing, discussing key common links and hot subfields, and aimed to promote industrial integration and cluster development [3] - The Hefei Biomanufacturing Provincial Future Industry Pilot Zone was officially approved in October 2024, with plans for the Hefei Synthetic Biomanufacturing Industrial Park [3] Group 2: Industry Development - The pilot zone has made significant progress in its first year, with major projects like the AI-driven biomanufacturing R&D base and microbial agent technology application base set to be completed soon [3] - The pilot zone currently hosts two listed biomanufacturing companies, with one more planning to go public next year, and five key enterprises are expected to achieve a combined output value of 4 billion yuan in 2024 [3][4] Group 3: Regional Focus - Anhui Province has established a comprehensive biomanufacturing industry system covering six sectors, with biopharmaceuticals, bio-foods, and bio-energy clusters each exceeding 10 billion yuan in scale [4] - Changfeng County aims to reach a biomanufacturing output value of 15 billion yuan by 2027 and over 30 billion yuan by 2030, with plans to establish four provincial-level innovation platforms and cultivate ten leading enterprises [5][7]

天眼查App显示，近日，扬州市恒一生物科技有限公司成立，法定代表人为葛祥俊，注册资本100万人 民币，经营范围为许可项目：检验检测服务（依法须经批准的项目，经相关部门批准后方可开展经营活 动，具体经营项目以审批结果为准）一般项目：生物化工产品技术研发；技术服务、技术开发、技术咨 询、技术交流、技术转让、技术推广；专用化学产品销售（不含危险化学品）；第一类医疗器械销售； 第二类医疗器械销售；实验分析仪器销售；仪器仪表销售；工程和技术研究和试验发展；细胞技术研发 和应用；医学研究和试验发展；自然科学研究和试验发展；农业科学研究和试验发展（除依法须经批准 的项目外，凭营业执照依法自主开展经营活动）。 ...

9月16日，记者从郑州市二七区人力资源和社会保障局获悉，该局联合河南123人才网将于9月18日 （周四）上午在郑州市二七区零工市场举办职引未来——全国城市联合招聘高校毕业生秋季专场招聘 会。 此次招聘对象主要为青年人才、高层次人才、应往届毕业生、离校未就业青年、社区待业青年、技 能型青年人才、退役军人等急需就业群体。重点参会企业涉及金融、生物化工、环保科技、教育培训、 机械制造、精密电子科技、智能数字化、旅游、文化传媒、法律、酒店餐饮、汽车、物流、医疗、农 牧、建材、食品等多个行业。岗位集中在新媒体运营、电子商务、技术工程师、行政、设计、会计、律 师、计算机、储备干部等，提供岗位6200余个。 为满足广大求职者对职业规划的需求，活动现场还将设立企业招聘区、企业展示区、手机端扫码投 递简历等方式，以便多元化服务求职者，进一步为求职青年进行岗位匹配和面对面推荐。 ...

Core Points - Changsha Jiayou Biotechnology Co., Ltd. has been established with a registered capital of 25 million RMB [1] - The company is involved in various sectors including food production, health food production, and food additives production [1] - The company also engages in research and development of biological chemical products, fermentation process optimization, and marine biological active substance extraction [1] Business Scope - The company operates under licensed projects such as food production, food sales, and health food production, which require approval from relevant authorities [1] - General projects include technology research and development, technical services, and the development of biological organic fertilizers and biopesticides [1] - The company is also involved in the retail and wholesale of cosmetics, as well as internet sales of various products [1]

Core Viewpoint - Jiangsu Lanfeng Bio-chemical Co., Ltd. has signed a settlement and debt waiver agreement with its controlling shareholder, Jiangsu Suhua Group Co., Ltd., to resolve investor litigation and debt issues, which is expected to alleviate the company's debt pressure and optimize its capital structure [1][7]. Summary by Sections Overview of the Settlement and Debt Waiver - The company faced investor lawsuits due to information disclosure violations, resulting in a compensation requirement of RMB 22,766,475.6, including overdue interest and litigation costs [2]. - As of July 31, 2025, the company owed Jiangsu Suhua Group a total of RMB 83,600,036.66, comprising RMB 59,200,719.70 in principal and RMB 24,399,316.96 in interest [2]. - The company has reached a settlement with Jiangsu Suhua Group regarding the investor lawsuits and debt waiver [2]. Key Terms of the Agreement - Jiangsu Suhua Group will bear a total compensation responsibility of RMB 17,157,200.73 for the investor lawsuits, which will be deducted from the company's outstanding loans to the group [5]. - The agreement includes a waiver of RMB 6,000,000 in interest debt by Jiangsu Suhua Group, which is unconditional and irrevocable [5]. - Following the agreement, the company will not pursue any further claims related to the investor lawsuits against Jiangsu Suhua Group or its management [6]. Impact of the Agreement on the Company - The total amount involved in the settlement and debt waiver is RMB 23,157,200, which will help reduce the company's debt burden and improve its asset-liability structure [7]. - The company will adjust its liabilities according to relevant accounting standards based on the audit results [7].

Group 1 - The event is a job fair titled "Hundred Days of Millions" aimed at providing job opportunities for recent graduates and unemployed youth in Zhengzhou [1] - The job fair will take place on September 4, from 9:00 AM to 12:00 PM, at the Zhengzhou Erqi District Labor Market [2] - Over 6,700 job positions will be available across various industries including finance, biotechnology, environmental technology, education, manufacturing, and more [1] Group 2 - The target audience includes recent graduates, unemployed graduates, and young talents seeking employment [1] - The job positions offered will cover roles such as new media operations, management trainees, e-commerce, technical engineers, and more [1] - The event will feature a recruitment area, company display area, and mobile resume submission options to enhance job matching and recommendations for job seekers [1]